Literature DB >> 22669434

[The application of botulinum toxin in oromandibular, pharyngeal and laryngeal dystonia].

A Olthoff1, R Laskawi.   

Abstract

Dystonias of the oral, pharyngeal and laryngeal muscles are potential causes of deglutitive, respiratory and communicative disorders. In addition to functional deficits such as dysphagia, dysarthria and dysphonia, social disadvantages may arise from the visible or audible manifestations. Treatment with botulinum toxin offers symptomatic and temporary therapeutic effects. Examples of applications in oromandibular dystonia, palatoclonus, dysphagia and laryngeal dystonia (e.g., spasmodic dysphonia) are described.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22669434     DOI： 10.1007/s00106-011-2477-7

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


  28 in total

1.  Botox for hyperadduction of the false vocal folds: a case report.

Authors:  C A Rosen; T Murry
Journal:  J Voice       Date:  1999-06       Impact factor: 2.009

2.  Successful treatment of autophonia with botulinum toxin: case report.

Authors:  Arno Olthoff; Rainer Laskawi; Eberhard Kruse
Journal:  Ann Otol Rhinol Laryngol       Date:  2007-08       Impact factor: 1.547

3.  Treatment of ventricular dysphonia with botulinum toxin.

Authors:  K A Kendall; R J Leonard
Journal:  Laryngoscope       Date:  1997-07       Impact factor: 3.325

4.  [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].

Authors:  R Laskawi; S Rohrbach
Journal:  Laryngorhinootologie       Date:  2001-12       Impact factor: 1.057

5.  Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.

Authors:  D D Troung; M Rontal; M Rolnick; A E Aronson; K Mistura
Journal:  Laryngoscope       Date:  1991-06       Impact factor: 3.325

6.  Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction.

Authors:  R Schönweiler; K Wohlfarth; R Dengler; M Ptok
Journal:  Laryngoscope       Date:  1998-01       Impact factor: 3.325

7.  Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.

Authors:  Lucian Sulica; Andrew Blitzer; Mitchell F Brin; Celia F Stewart
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-06       Impact factor: 1.547

8.  Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.

Authors:  Chih-Ying Su; Chi-Chih Lai; Pei-Yin Wu; Hsun-Hsien Huang
Journal:  Laryngoscope       Date:  2010-02       Impact factor: 3.325

9.  Service-based survey of dystonia in munich.

Authors:  E Castelon Konkiewitz; I Trender-Gerhard; C Kamm; T Warner; Y Ben-Shlomo; T Gasser; B Conrad; A O Ceballos-Baumann
Journal:  Neuroepidemiology       Date:  2002 Jul-Aug       Impact factor: 3.282

Review 10.  Botulinum toxin injections for the treatment of spasmodic dysphonia.

Authors:  C C W Watts; R Whurr; C Nye
Journal:  Cochrane Database Syst Rev       Date:  2004
View more
  1 in total

Review 1.  [Botulinum toxin in otorhinolaryngology - an update].

Authors:  R Laskawi; A Olthoff
Journal:  HNO       Date:  2017-10       Impact factor: 1.284
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.